Press release
Fibrate Drugs Market Trends That Will Shape the Next Decade: Insights from Innovations Propel Growth In Fibrates Drugs Market
Fibrate Drugs Market
How Large Will the Fibrate Drugs Market Size By 2025?
The market size of fibrate drugs has been consistently expanding in the past few years. The market is foreseen to rise from $3.49 billion in 2024 to $3.62 billion in 2025, with a compound annual growth rate (CAGR) of 3.8%. Factors contributing to this growth during the historic period include the evolution of lipid management, focus on cholesterol management, clinical research and trials, reduction in cardiovascular risk, and combination therapies.
How Big Is the Fibrate Drugs Market Size Expected to Grow by 2029?
A significant increase is anticipated in the fibrate drugs market size in the coming years. It is predicted to reach $4.81 billion by 2029, with a compound annual growth rate (CAGR) of 7.4%. The growth projected for the forecast period can be ascribed to the evolution of treatment guidelines, concentration on residual risk, advancements in precision medicine, and drug delivery innovations. Key trends expected during the forecast period encompass alternative formulations, the incorporation of telemedicine, the use of fibrates in high-risk groups, focusing on triglyceride levels, and emphasis on raising HDL.
View the full report here:
https://www.thebusinessresearchcompany.com/report/fibrate-drugs-global-market-report
Which Key Market Drivers Powering Fibrate Drugs Market Expansion and Growth?
The rise in cardiac disease cases is likely to drive the fibrate drug market's trajectory upwards. Cardiac diseases, which include conditions that affect the heart and blood vessels, such as coronary heart disease, congenital heart disease, and others, are on the rise. Fibrates are often employed to prevent additional heart attacks and strokes in individuals who already have circulatory system conditions, which fuels the fibrate drug market's growth. For example, the Singapore Heart Foundation (SHF), a non-profit organization in Singapore, reported that ischemic heart diseases caused 5,302 deaths in May 2024, a small increase from the 5,290 deaths recorded in 2022. Further, the death count attributable to hypertensive diseases increased to 3.7% in 2022, a rise from 3.4% in 2021. Hence, the spiraling frequency of cardiac diseases is a primary driver for the expanding fibrate drug market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11932&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Fibrate Drugs Market?
Major players in the fibrate drugs industry are concentrating on the creation of innovative, fixed-dose combinations to maintain their market dominance. A fixed-dose concoction is a pharmaceutical compound that contains two or more active constituents in one dose, offering more straightforward administration and possibly enhancing therapy results. For instance, in May 2023, the U.S. Food and Drug Administration (FDA) gave Intercept Pharmaceuticals Inc., an American biopharmaceutical firm, the green light for orphan drug designation for their fixed-dose blend of obeticholic acid (OCA) and bezafibrate. This mix, a Peroxisome Proliferator-Activated Receptor (PPAR) stimulant, is being studied for the potential treatment of people with primary biliary cholangitis (PBC). OCA, a Farnesoid X Receptor (FXR) stimulant, is sold by Intercept under the brand name Ocaliva for PBC treatment in the U.S, but bezafibrate, a pan-PPAR stimulant, is yet to receive any approval in the U.S for any application.
What Are the Emerging Segments in the Fibrate Drugs Market?
The fibrate drugs market covered in this report is segmented -
1) By Drug Type: Clofibrate, Fenofibrates, Fenofibric Acids, Gemfibrozil, Other Drugs
2) By Indication: Hypercholesterolemia, Heart Attacks, Other Indications
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Clofibrate: Standard Clofibrate, Combination Products
2) By Fenofibrates: Fenofibrate Capsules, Fenofibrate Tablets, Combination Products
3) By Fenofibric Acids: Fenofibric Acid Capsules, Combination Products
4) By Gemfibrozil: Standard Gemfibrozil, Combination Products
5) By Other Drugs: Other Fibrate Formulations, Emerging Fibrate Drugs
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11932&type=smp
Who Are the Global Leaders in the Fibrate Drugs Market?
Major companies operating in the fibrate drugs market include Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Kowa Company Ltd., Bristol-Myers Squibb Co, Abbott Laboratories, AstraZeneca plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Co Ltd., Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Inc., Zydus Lifesciences Ltd, Lupin Limited, Glenmark Pharmaceuticals, Torrent Pharmaceuticals Ltd., Natco Pharma, Hetero Drugs Ltd
Which are the Top Profitable Regional Markets for the Fibrate Drugs Industry?
North America was the largest region in the fibrate drugs market in 2024. The regions covered in the fibrate drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11932
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fibrate Drugs Market Trends That Will Shape the Next Decade: Insights from Innovations Propel Growth In Fibrates Drugs Market here
News-ID: 4098611 • Views: …
More Releases from The Business Research Company
Surge in Traveler Numbers To Drive the Driving Vacation Market: Powering Innovat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Driving Vacation Market Through 2025?
The market size for driving vacations has seen a swift expansion in the past few years. The projection for growth is from $159.93 billion in 2024 up to $184.84 billion in 2025, which means a compound annual…
Spa Market Trends That Will Shape the Next Decade: Insights from Revolutionizing …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Spa Market Size By 2025?
The size of the spa market has seen a swift expansion in the past few years. Its growth is projected to escalate from $72.32 billion in 2024 to $80.06 billion in 2025, registering a Compound Annual Growth Rate (CAGR) of…
2025-2034 Coastal And Maritime Tourism Market Evolution: Disruptions, Innovation …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Coastal And Maritime Tourism Market Through 2025?
The market size of coastal and maritime tourism has seen robust growth in the preceding years. The market is projected to expand from $3010.38 billion in 2024 to $3223.34 billion in 2025, boasting a compound…
Global Tourism Event Market Projected to Grow at 3.8% CAGR, Reaching $2073.59 Bi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tourism Event Industry Market Size Be by 2025?
Over the past few years, the tourism event market size has consistently expanded. With a compound annual growth rate (CAGR) of 4.5%, it's projected to rise from $1709.7 billion in 2024 to $1785.93 billion in 2025. The significant…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
